Paul Bruinenberg

Paul Bruinenberg is currently the Chief Medical Officer at Vast Therapeutics, focusing on rare diseases and pulmonary diseases since March 2024. Previously, Paul served as Senior Medical Officer at TB Alliance from April 2017 to August 2023, specializing in rare diseases and clinical development. Paul also held the position of Interim CEO and CMO at Tiara Pharmaceuticals from January 2016 to January 2018, and before that, worked as Chief Medical Officer and Head of R&D at Eagle Pharmaceuticals, Inc. from January 2011 to January 2016. Additionally, Paul was a Senior Medical Director and Chief Medical Officer at Aradigm Corporation from January 2007 to January 2011. Paul holds an MBA from Nyenrode Business University and an MD from Stellenbosch University.